According to OraSure Technologies's latest financial reports the company has a price-to-book ratio of 1.04.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2022-12-31 | 0.9626 | -41.48% |
2021-12-31 | 1.65 | -13.65% |
2020-12-31 | 1.91 | 18.05% |
2019-12-31 | 1.61 | -36.1% |
2018-12-31 | 2.53 | -43.01% |
2017-12-31 | 4.43 | 68.34% |
2016-12-31 | 2.63 | 17.01% |
2015-12-31 | 2.25 | -37.32% |
2014-12-31 | 3.59 | 65.32% |
2013-12-31 | 2.17 | -6.82% |
2012-12-31 | 2.33 | -45.69% |
2011-12-31 | 4.29 | 66.03% |
2010-12-31 | 2.58 | 14.99% |
2009-12-31 | 2.25 | 44.21% |
2008-12-31 | 1.56 | -47.36% |
2007-12-31 | 2.96 | 0.92% |
2006-12-31 | 2.93 | -13.59% |
2005-12-31 | 3.40 | -14.45% |
2004-12-31 | 3.97 | -17.2% |
2003-12-31 | 4.79 | -39.94% |
2002-12-31 | 7.98 |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
![]() Quest Diagnostics
DGX | 2.18 | 108.79% | ๐บ๐ธ USA |
![]() Cooper Companies COO | 2.20 | 110.71% | ๐บ๐ธ USA |
![]() Trinity Biotech
TRIB | -3.94 | -476.97% | ๐ฎ๐ช Ireland |
![]() QuidelOrtho QDEL | 0.9680 | -7.37% | ๐บ๐ธ USA |
![]() Chembio Diagnostics CEMI | 0.9389 | -10.15% | ๐บ๐ธ USA |
![]() Bio-Rad Laboratories BIO | 1.24 | 18.31% | ๐บ๐ธ USA |